Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumi Higuchi

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Cancer Cell|October 3, 2017
Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant GliomaChristian J Braun, Monica Stanciu, Paul L Boutz, et al.
Neurologia Medico-Chirurgica|December 3, 2013
A Multicenter Phase I/II Study of the BCNU Implant (Gliadel<sup>®</sup> Wafer) for Japanese Patients with Malignant GliomasTomokazu Aoki, Ryo Nishikawa, Kazuhiko Sugiyama, et al.
Neurologia Medico-Chirurgica|April 18, 2014
A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomasTomokazu Aoki, Ryo Nishikawa, Kazuhiko Sugiyama, et al.
Scientific Reports|February 15, 2019
DNA demethylation is associated with malignant progression of lower-grade gliomasMasashi Nomura, Kuniaki Saito, Koki Aihara, et al.
Scientific Reports|May 24, 2019
Publisher Correction: DNA demethylation is associated with malignant progression of lower-grade gliomasMasashi Nomura, Kuniaki Saito, Koki Aihara, et al.
Acta Neuropathologica|June 20, 2021
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastomaKenji Fujimoto, Hideyuki Arita, Kaishi Satomi, et al.
Cancers|April 3, 2021
Fine-Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among FacilitiesSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
NPJ Digital Medicine|May 5, 2026
Comparing artificial intelligence and physician performance in predicting IDH mutation status in gliomaSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Neuro-Oncology|November 4, 2024
Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up studyHirokazu Takami, Masao Matsutani, Tomonari Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2018
Genotype-targeted local therapy of gliomaGanesh M Shankar, Ameya R Kirtane, Julie J Miller, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancer Cell|October 3, 2017
Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant GliomaChristian J Braun, Monica Stanciu, Paul L Boutz, et al.
Neurologia Medico-Chirurgica|December 3, 2013
A Multicenter Phase I/II Study of the BCNU Implant (Gliadel<sup>®</sup> Wafer) for Japanese Patients with Malignant GliomasTomokazu Aoki, Ryo Nishikawa, Kazuhiko Sugiyama, et al.
Neurologia Medico-Chirurgica|April 18, 2014
A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomasTomokazu Aoki, Ryo Nishikawa, Kazuhiko Sugiyama, et al.
Scientific Reports|February 15, 2019
DNA demethylation is associated with malignant progression of lower-grade gliomasMasashi Nomura, Kuniaki Saito, Koki Aihara, et al.
Scientific Reports|May 24, 2019
Publisher Correction: DNA demethylation is associated with malignant progression of lower-grade gliomasMasashi Nomura, Kuniaki Saito, Koki Aihara, et al.
Acta Neuropathologica|June 20, 2021
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastomaKenji Fujimoto, Hideyuki Arita, Kaishi Satomi, et al.
Cancers|April 3, 2021
Fine-Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among FacilitiesSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
NPJ Digital Medicine|May 5, 2026
Comparing artificial intelligence and physician performance in predicting IDH mutation status in gliomaSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Neuro-Oncology|November 4, 2024
Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up studyHirokazu Takami, Masao Matsutani, Tomonari Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2018
Genotype-targeted local therapy of gliomaGanesh M Shankar, Ameya R Kirtane, Julie J Miller, et al.
Pageof 4